Invasive versus Conservative Treatment Approach among Older Adult Patients Admitted with Acute ST-Segment Elevation

Keren-Lee Rozenfeld1, Lior Lupu1, Ilan Merdler1

  • 1Department of Cardiology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Insights

Primary percutaneous coronary intervention (PCI) significantly improves survival in older adults with ST-elevation myocardial infarction (STEMI). This invasive strategy offers a survival benefit compared to conservative treatment in this vulnerable patient group.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • ST-elevation myocardial infarction (STEMI) management guidelines prioritize primary percutaneous coronary intervention (PCI).
  • The effectiveness and safety of primary PCI in very elderly patients (over 75 years) with STEMI require further investigation.

Purpose of the Study:

  • To evaluate the efficacy and safety of primary PCI compared to conservative management in patients over 75 years old diagnosed with acute STEMI.
  • To assess 30-day mortality and in-hospital complications in this elderly STEMI population.

Main Methods:

  • Retrospective, single-center observational study of 530 patients aged >75 years with STEMI.
  • Primary PCI was administered for symptom onset within 12 hours; others received conservative treatment.
  • Data on 30-day mortality and hospitalization complications were analyzed.

Main Results:

  • Only 5% of patients (28/530) were managed conservatively.
  • No significant differences in in-hospital complications like inotropic support or mechanical ventilation were observed between groups.
  • The conservative group had a substantially higher risk of 30-day mortality (27% vs. 10%, p=0.02) and a trend towards increased heart failure incidence.

Conclusions:

  • Primary PCI in elderly STEMI patients (>75 years) is associated with a significant survival benefit.
  • Despite potential safety concerns, primary PCI should be considered a viable treatment strategy for older adults with STEMI.
  • The study supports the use of primary PCI in elderly STEMI patients, challenging previous uncertainties about its efficacy in this demographic.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
15
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
29